We continuously develop and expand our robust pipeline to address patients' unmet medical needs. Our pursuit of new medicines is fueled by the scientific curiosity of our employees, a willingness to examine new ideas, and the pairing of existing information with novel concepts.

Please note that the medicines in the pipeline below are currently under clinical trial investigation and are not yet approved.

Pipeline Chart

* As of Oct 31, 2024

Pipeline Chart

5DXd ADCs

ENHERTU Dato-DXd HER3-DXd DS-7300 (I-DXd) DS-6000 (R-DXd)

Enlargeable images of 5DXd ADCs pipeline are here in separate windows

Phase 1, Phase 1/2, Phase 2

Phase 2/3, Phase 3, Regulatory phase

Next Wave

Oncology Specialty Medicine Vaccine

Enlargeable image of Next Wave pipeline opens here in separate window